Charging patients for HIV drugs is a barrier to treatmentBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39056.466539.DB (Published 07 December 2006) Cite this as: BMJ 2006;333:1192
- Claire Frauenfelder
Charging patients for HIV treatment is proving a barrier to treatment, health experts said last week at a conference in Geneva organised by the charity Médecins Sans Frontières.
Charging for antiretrovirals “creates an economic problem for patients but also a public health problem for everyone else,” said Yves Souteyrand, of the World Health Organization.
“Cost is the major barrier, over and above all others,” explained Dr Souteyrand, citing data collected in Senegal showing that removing charges increased adherence by 20%. …
Log in using your username and password
Log in through your institution
Sign up for a free trial